<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hibernicor</title>
	<atom:link href="https://hibernicor.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://hibernicor.com</link>
	<description>Heart Preservation Solutions that Save Lives</description>
	<lastBuildDate>Mon, 15 Sep 2025 21:02:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>

<image>
	<url>https://hibernicor.com/wp-content/uploads/2017/05/cropped-square-512b-32x32.png</url>
	<title>Hibernicor</title>
	<link>https://hibernicor.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Hibernicor Installs State-of-The-Art Cleanroom</title>
		<link>https://hibernicor.com/hibernicor-installs-state-of-the-art-cleanroom/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Mon, 15 Sep 2025 20:11:00 +0000</pubDate>
				<category><![CDATA[Milestones]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=4443016</guid>

					<description><![CDATA[Hibernicor announces the installation of a new cleanroom at its Jackson, Mississippi facility.  This ISO Class 6 cleanroom is intended for the company's production of high-quality single-use containers for Asporto and other contract products in the single use industry.  The 10' x 14' clean room allows production of containers in quality-controlled environment designed to reduce]]></description>
		
		
		
			</item>
		<item>
		<title>What are the barriers to wider use of organ perfusion?</title>
		<link>https://hibernicor.com/what-are-the-barriers-to-wider-use-of-organ-perfusion/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Wed, 22 Feb 2023 19:35:34 +0000</pubDate>
				<category><![CDATA[Industry Literature]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=1725972</guid>

					<description><![CDATA[INSIGHTS UNOS Chief Medical Officer David Klassen, M.D., discusses perfusion-driven advances and remaining challenges Normothermic perfusion continues to show promise as an innovation that will help increase the number of donor organs available for transplant. With perfusion, circulation and normal body temperature and function are maintained for the organ, making it possible both to evaluate]]></description>
		
		
		
			</item>
		<item>
		<title>Another record year for heart transplants: Steep increases seen in DCD transplants in 2022</title>
		<link>https://hibernicor.com/another-record-year-for-heart-transplants-steep-increases-seen-in-dcd-transplants-in-2022/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Tue, 14 Feb 2023 19:56:25 +0000</pubDate>
				<category><![CDATA[Industry Literature]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=1691464</guid>

					<description><![CDATA[in focus A 68% increase in DCD heart transplants was part of a record-setting 2022 The 11th straight year of increases in heart transplants coincides with advancements in organ perfusion technology and DCD recovery practices. In 2022, 42,888 organ transplants were performed in the United States, an increase of 3.7 percent over 2021 and a]]></description>
		
		
		
			</item>
		<item>
		<title>Process Engineer</title>
		<link>https://hibernicor.com/process-engineer/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Wed, 10 Aug 2022 16:42:52 +0000</pubDate>
				<category><![CDATA[Job Opportunities]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=1071826</guid>

					<description><![CDATA[Job Title: Process Engineer Summary:  The process engineer is responsible for the installation, qualification, operation, supervision of a biomedical device assembly facility clean room.  The role includes developing standard operating protocols, training materials, scheduling, and reporting activities for manufacturing within a regulatory controlled environment.  This includes operations of the facility, electrical, process equipment , HVAC,]]></description>
		
		
		
			</item>
		<item>
		<title>UNOS CEO Brian Shepard to leave organization after a decade of service</title>
		<link>https://hibernicor.com/unos-ceo-brian-shepard-to-leave-organization-after-a-decade-of-service/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Tue, 28 Jun 2022 16:19:57 +0000</pubDate>
				<category><![CDATA[Industry Literature]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=1007099</guid>

					<description><![CDATA[United Network for Organ Sharing (UNOS) today announced that CEO Brian Shepard will depart the organization at the end of September, following the completion of his contract. Shepard’s 10-year tenure as UNOS CEO was marked by groundbreaking progress in the U.S. organ donation and transplantation system. Maureen McBride, Ph.D., UNOS’ chief operating officer, will assume]]></description>
		
		
		
			</item>
		<item>
		<title>[Approval] Preservation by cold storage vs ex vivo normothermic perfusion of marginal donor hearts: clinical, histopathologic, and ultrastructural features</title>
		<link>https://hibernicor.com/approval-preservation-by-cold-storage-vs-ex-vivo-normothermic-perfusion-of-marginal-donor-hearts-clinical-histopathologic-and-ultrastructural-features-11/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Thu, 19 Aug 2021 12:31:11 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=4044227</guid>

					<description><![CDATA[Approve this article for publicationDelete this articleJ Heart Lung Transplant. 2020 Dec;39(12):1408-1416. doi: 10.1016/j.healun.2020.08.021. Epub 2020 Sep 4.ABSTRACTBACKGROUND: The aim of this study was to match clinical outcomes of heart transplantation (HTx) against histopathologic and ultrastructural characteristics of marginal grafts preserved by cold storage (CS) or ex vivo normothermic perfusion.METHODS: Since 2011, 100 patients had]]></description>
		
		
		
			</item>
		<item>
		<title>[Approval] Does pediatric heart transplant survival differ with various cardiac preservation solutions?</title>
		<link>https://hibernicor.com/approval-does-pediatric-heart-transplant-survival-differ-with-various-cardiac-preservation-solutions-11/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Thu, 19 Aug 2021 12:31:10 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=4044226</guid>

					<description><![CDATA[Approve this article for publicationDelete this articleClin Transplant. 2020 Dec;34(12):e14122. doi: 10.1111/ctr.14122. Epub 2020 Nov 22.ABSTRACTBACKGROUND: Few studies directly compare outcomes between the most commonly used preservation solutions in pediatric heart transplantation in a large cohort of recipients. The purpose of this study is to investigate the effect of cardiac preservation solution on survival in]]></description>
		
		
		
			</item>
		<item>
		<title>[Approval] Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival</title>
		<link>https://hibernicor.com/approval-impact-of-porcine-cytomegalovirus-on-long-term-orthotopic-cardiac-xenotransplant-survival-11/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Thu, 19 Aug 2021 12:31:10 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=4041075</guid>

					<description><![CDATA[Approve this article for publicationDelete this articleSci Rep. 2020 Oct 16;10(1):17531. doi: 10.1038/s41598-020-73150-9.ABSTRACTXenotransplantation using pig organs has achieved survival times up to 195 days in pig orthotopic heart transplantation into baboons. Here we demonstrate that in addition to an improved immunosuppressive regimen, non-ischaemic preservation with continuous perfusion and control of post-transplantation growth of the transplant,]]></description>
		
		
		
			</item>
		<item>
		<title>[Approval] Heart transplantation of patients with ventricular assist devices: impact of normothermic ex-vivo preservation using organ care system compared with cold storage</title>
		<link>https://hibernicor.com/approval-heart-transplantation-of-patients-with-ventricular-assist-devices-impact-of-normothermic-ex-vivo-preservation-using-organ-care-system-compared-with-cold-storage-11/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Thu, 19 Aug 2021 12:31:09 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=4037474</guid>

					<description><![CDATA[Approve this article for publicationDelete this articleJ Cardiothorac Surg. 2020 Oct 27;15(1):323. doi: 10.1186/s13019-020-01367-w.ABSTRACTBACKGROUND: Organ Care System (OCS) minimizes the cold ischemic time and allows for optimization of logistics and meticulous recipient preparation. Impact of normothermic ex-vivo preservation using OCS compared with cold storage (CS) for prolonged heart preservation especially beneficial for high-risk recipients bridged]]></description>
		
		
		
			</item>
		<item>
		<title>[Approval] Ex situ heart perfusion: The past, the present, and the future</title>
		<link>https://hibernicor.com/approval-ex-situ-heart-perfusion-the-past-the-present-and-the-future-11/</link>
		
		<dc:creator><![CDATA[Andrew Rivard]]></dc:creator>
		<pubDate>Thu, 19 Aug 2021 12:31:08 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://hibernicor.com/?p=4034023</guid>

					<description><![CDATA[Approve this article for publicationDelete this articleJ Heart Lung Transplant. 2021 Jan;40(1):69-86. doi: 10.1016/j.healun.2020.10.004. Epub 2020 Oct 14.ABSTRACTDespite the advancements in medical treatment, mechanical support, and stem cell therapy, heart transplantation remains the most effective treatment for selected patients with advanced heart failure. However, with an increase in heart failure prevalence worldwide, the gap between]]></description>
		
		
		
			</item>
	</channel>
</rss>
